Histology and Cell Biology: An Introduction to Pathology. Edition No. 4 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The Histology and Cell Biology: An Introduction to Pathology. Edition No. 4 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

Fully integrating histology, cell biology, and pathology, the 4th Edition of the award-winning Histology and Cell Biology: An Introduction to Pathology presents key concepts in an understandable, easy-to-digest manner. Authors Abraham L. Kierszenbaum, MD, PhD and Laura L. Tres MD, PhD link basic science to clinical application throughout, focusing on what you need to know for your coursework now – and how to apply that information in a clinical setting . Full-color illustrations on every page, as well as unique, student-friendly features online, help you quickly grasp the complexities of pathologic abnormalities.

Read more and order at Histology and Cell Biology: An Introduction to Pathology. Edition No. 4

Nutrition and Cancer – Healthcare, Healthcare Services Industries

The Nutrition and Cancer Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services Markets.

The role of nutrition in cancer treatments should not be underestimated; within a clinical setting, carefully considered nutritional options can help to control cachexia, the patient′s ability to cope with treatments such as chemotherapy and the ability to recover from invasive surgery.

Edited by Dr Clare Shaw, Head of Rehabilitation Research at the Royal Marsden Hospital, Nutrition and Cancer Care takes an unrivalled look at this prevalent disease, offering the reader:

  • A practical guide to good nutrition and dietetic practice in cancer care
  • A detailed look at nutritional options for different diagnostic groups and disease states
  • Contributions from a wide range of cancer specialists

An excellent resource for dietitans, clinical nutritionists, doctors, nurses and other health professionals working with cancer patients this book is also a fascinating reference for students and researchers with an interest in the area.

Read more and order at Nutrition and Cancer

Managing Risks Under HIPAA – Webinar – Healthcare, Healthcare Services, Managed Care Industries

The Managing Risks Under HIPAA – Webinar Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Managed Care Markets.

This lesson will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order as HIPAA is now fully enforced and the government is not using kid gloves any more.

It will also address major changes under the Omnibus Rule and any other applicable updates for 2017 and beyond. There are an enormous amount of issues and risks for covered entities and business associates these days.

I will speak on specific experiences from over 17 years of experience in working as an outsourced compliance auditor, expert witness on multiple HIPAA cases, and thoroughly explain how patients are now able to get cash remedies for wrongful disclosures of private health information.

More importantly I will show you how to limit those risks by simply taking proactive steps and utilizing best practices.

Why Should You Attend? Omnibus has changed the HIPAA landscape for good!
This once rarely enforced law has changed and you need to know what's going on!
Protect your practice or business!
These day's trial attorney's pose a higher risk than the Federal government!
State laws are now in place increasing liability for patient remedies!
What factors might spurn a lawsuit or a HIPAA audit? …are you doing these things?

Why are the Feds enforcing after all these years? We will be discussing 2017 changes taking place in Washington with the Health and Human Services in regards to the enforcement of the HIPAA laws already on the books as well as some detailed discussions on the audit process as well as some current events regarding HIPAA cases (both in courtrooms and from live audits)

Areas Covered in the Session:

Updates for 2017
Fines
Portable devices
Real life audits and litigated cases
Business associates and the increased burden
Breach notification
Paperwork that needs to be updated
Risk factors

Read more and order at Managing Risks Under HIPAA – Webinar

Blood Collection and Processing Supplies – Global Strategic Business Report – Blood Banking, Healthcare, Healthcare Services Industries

The Blood Collection and Processing Supplies – Global Strategic Business Report Report has been published. It provides updated in 2018 year analysis of industries from Blood Banking, Healthcare, Healthcare Services Markets.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

This report analyzes the worldwide markets for Blood Collection and Processing Supplies in US$ by the following Product Segments: Blood Administration Sets, Blood Collection Needles, Blood Collection Tubes & Micro Collectors, Blood Lancets, Blood Bags, Blood Grouping Reagents, Coagulation Reagents, Hematology Reagents, Microscopic Slides, Slide Stainers, Test Tube Racks, and Vials.

The report profiles 121 companies including many key and niche players such as –

AdvaCare Pharmaceuticals
Beckman Coulter, Inc.
Becton, Dickinson and Company
Fresenius Kabi AG
Grifols International S.A

Read more and order at Blood Collection and Processing Supplies – Global Strategic Business Report

Global and Chinese Vaginal pessarie Industry – 2017 – Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Industries

The Global and Chinese Vaginal pessarie Industry – 2017 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Markets.

The 'Global and Chinese Vaginal pessarie Industry – 2017' is a professional and in-depth study on the current state of the global Vaginal pessarie industry with a focus on the Chinese market. The report provides key statistics on the market status of the Vaginal pessarie manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company.

Through the statistical analysis, the report depicts the global and Chinese total market of the Vaginal pessarie industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2017-2022 market development trends of the Vaginal pessarie industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

In the end, the report makes some important proposals for a new project of the Vaginal pessarie Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2012-2022 global and Chinese Vaginal pessarie industry covering all important parameters.

PLEASE NOTE: This report will be completed after order and will take approximately 2-3 business days after the confirmation of payment.

Read more and order at Global and Chinese Vaginal pessarie Industry – 2017

2017 Spain Transfusion Diagnostics Market: Future Horizons and Growth Strategies-Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities – Blood Banking, Healthcare, Healthcare Services Industries

The 2017 Spain Transfusion Diagnostics Market: Future Horizons and Growth Strategies-Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities Report has been published. It provides updated in 2018 year analysis of industries from Blood Banking, Healthcare, Healthcare Services Markets.

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Spanish transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in Spain; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin,
Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc,
HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates for leading suppliers
of transfusion diagnostic products by individual product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

– Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers.

– Test volume and sales forecasts for over 40 blood typing,
grouping and infectious disease screening tests,
including NAT, by country and market segment:

– Blood Centers
– Hospitals
– Commercial/Private Laboratories

Current and Emerging Products

– Analysis of current and emerging blood typing,
grouping and infectious disease screening tests.

– Review of automated and semi-automated
analyzers.

Technology Review

– Assessment of current and emerging
technologies, and their potential applications
for the transfusion diagnostics market.

– Comprehensive lists of companies developing
or marketing new technologies and products, by test.

Strategic Recommendations

– New product development opportunities
with significant market appeal.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

Contains 425 pages and 42 tables

Read more and order at 2017 Spain Transfusion Diagnostics Market: Future Horizons and Growth Strategies-Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Columns for Gas Chromatography. Performance and Selection – Diagnostics, Healthcare, Healthcare Services, Laboratory Testing Industries

The Columns for Gas Chromatography. Performance and Selection Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, Laboratory Testing Markets.

Choosing the right column is key in Gas Chromatography

Gas Chromatography (GC) is the most widely used method for separating and analyzing a wide variety of organic compounds and gases. There have been many recent advancements in both packed column and capillary column GC. With numerous options and considerations, selecting the right column can be complicated. This resource provides essential guidance for scientists and technicians, including:

  • Methods of choosing both capillary and packed columns

  • Selection of dimensions (column length, I.D., film thickness, etc.) and type of column

  • Guidelines for proper connections of the column to the injector and detector

  • United States Pharmacopeia and National Formulary chromatographic methods

  • ASTM, EPA, NIOSH, and OSHA column selection specifications

  • Information on the advantages of computer assistance in GC and multidimensional GC

  • Comprehensive information on column oven temperature control

Columns for Gas Chromatography: Performance and Selection is a hands–on reference for scientists and technicians using GC.

Read more and order at Columns for Gas Chromatography. Performance and Selection

2017 Austria Hemostasis Diagnostics Market: Reagent and Volume Forecasts for 40 Assays, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers – Coagulation and Hemostasis Testing, Diagnostics, Healthcare, Healthcare Services Industries

The 2017 Austria Hemostasis Diagnostics Market: Reagent and Volume Forecasts for 40 Assays, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers Report has been published. It provides updated in 2018 year analysis of industries from Coagulation and Hemostasis Testing, Diagnostics, Healthcare, Healthcare Services Markets.

Summary

This comprehensive report contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years.

The report explores market and technological trends; provides reagent, instrument and test volume for 40 coagulation procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests Analyzed in the Report

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Competitive Assessments

– Extensive strategic profiles of major suppliers and emerging market entrants.

Current and Emerging Products

– Review of established and emerging procedures.

– Comparison of automated and semi-automated analyzers.

Technology Review

– Analysis of current and emerging technologies and their potential market applications.

– Comprehensive listings of companies developing or marketing new technologies and products by test.

Strategic Recommendations

– Product development and business expansion opportunities with significant market appeal.

– Alternative market penetration strategies for instrument and reagent suppliers.

– Potential market entry barriers and risks.

Contains 350 pages and 22 tables

Read more and order at 2017 Austria Hemostasis Diagnostics Market: Reagent and Volume Forecasts for 40 Assays, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

The Placenta. From Development to Disease – Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Industries

The The Placenta. From Development to Disease Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Markets.

The Placenta – friend not foe

The placenta is central to the survival of the fetus. Placental dysfunction, whether from disease or maldevelopment, therefore threatens the fetus and its mother. Disruption to normal placental function can disrupt fetal development in ways that are not apparent until long after birth. The crucial role of the placenta for fetal well being, the developmental origins of human adult disease and cardiovascular health and maternal placental syndromes is now being unravelled.

The Placenta: From Development to Disease examines research into placental function and its clinical implications to provide a springboard for improving clinical practice and enhancing medical research. Influential information is extracted from the compelling narrative by the use of ′take home′ features including:

  • Clinical Pearls point to important issues in clinical practice
  • Research Spotlights highlight key insights into placental understanding
  • Teaching Points explain basic concepts for novice readers

The Placenta: From Development to Disease is ideal for both experienced clinicians and researchers and those new to the field. Anyone who needs to understand the central importance of the placenta in the well being of their maternal and fetal patients should read this book.

Read more and order at The Placenta. From Development to Disease

2017 U.S. Assisted Daily Living Srvcs – Physical/Occupational Rehab Srvcs Sold Through Community Care Facilities for the Elderly – Product & Services Report – Healthcare, Healthcare Services, Nursing Industries

The 2017 U.S. Assisted Daily Living Srvcs – Physical/Occupational Rehab Srvcs Sold Through Community Care Facilities for the Elderly – Product & Services Report Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Nursing Markets.

The 2017 U.S. Assisted daily living srvcs – Physical/occupational rehab srvcs sold through Community care facilities for the elderly – Product & Services Report, published annually, contains timely and accurate industry statistics, forecasts and demographics.

The report features 2017 current and 2018 forecast estimates on the sales of Assisted daily living srvcs – Physical/occupational rehab srvcs sold through Community care facilities for the elderly nationally and for all 50 U.S. States and up to 900 metro areas.

Read more and order at 2017 U.S. Assisted Daily Living Srvcs – Physical/Occupational Rehab Srvcs Sold Through Community Care Facilities for the Elderly – Product & Services Report